TOXICOLOGY LETTERS is a prominent journal dedicated to advancing the field of toxicology, providing a platform for high-quality research and reviews that explore the effects of chemical substances on biological systems. Published by Elsevier Ireland Ltd, this peer-reviewed journal has established itself as a vital resource in toxicological research since its inception in 1977, with a convergence of studies extending to 2024. With an impressive Scopus ranking, positioned at #28 out of 133 in the Toxicology category, TOXICOLOGY LETTERS garners a respectable percentile of 79, highlighting its significance in the academic community. Although it is not an open-access journal, its research is accessible through institutional subscriptions, ensuring that critical insights into human health and environmental safety are disseminated effectively. Being categorized in the Q2 quartile in both Medicine (miscellaneous) and Toxicology for 2023 further emphasizes its relevance and impact in these fields. This journal aims to foster collaboration between researchers and professionals, encouraging the exploration of innovative solutions to chemical hazards and the promotion of safer practices in pharmacology and toxicology.

Toxicon-X is a prestigious journal published by ELSEVIER, specializing in the dynamic field of toxicology. With an impact factor indicative of its excellence and rigor—ranked Q1 in Toxicology as of 2023, and positioned at #40 out of 133 in Scopus's Pharmacology, Toxicology, and Pharmaceutics category—this journal is a vital resource for researchers, practitioners, and students alike. Since its inception in 2019, Toxicon-X has embraced an Open Access model, enhancing accessibility and transparency of research findings. This ensures that crucial studies on toxic agents and their effects reach a broader audience, driving advancements in public health and safety. The journal is based in the United Kingdom and caters to a diverse international readership, with its scope encompassing novel research, reviews, and insights into emerging toxicological challenges. As we move towards the 2024 convergence year, Toxicon-X remains committed to fostering a deeper understanding of toxic substances, their mechanisms, and implications for human and environmental health.

CHEMICO-BIOLOGICAL INTERACTIONS is a premier journal published by Elsevier Ireland Ltd, dedicated to advancing the field of chemical and biological interactions since its inception in 1969. With a robust focus on pharmacology and toxicology, the journal holds a prestigious Q1 ranking in both Medicine (miscellaneous) and Toxicology, reflecting its significance in disseminating influential research. As part of the Scopus database, it ranks #21 out of 133 journals in Toxicology, positioning it in the 84th percentile and ensuring high visibility for cutting-edge studies. This scholarly platform serves as a crucial resource for researchers, professionals, and students who seek reliable and innovative findings at the intersection of chemistry and biology. While currently not open access, CHEMICO-BIOLOGICAL INTERACTIONS provides a comprehensive collection of articles that contribute to the ongoing dialogue in toxin research and its implications on medicinal chemistry, thereby fostering advancements in public health and safety.

Toxins, published by MDPI, is a leading open-access journal specializing in the field of toxicology, with a strong emphasis on the health implications of toxins across various environments. Established in 2009, this journal has quickly ascended to prominence, attaining a Q1 ranking in both the Health, Toxicology and Mutagenesis and Toxicology categories, underscoring its significant contribution to the scientific community. With an impressive Scopus ranking, placing it within the top percentile of related fields, Toxins serves as a vital resource for researchers, professionals, and students dedicated to advancing knowledge in toxicology and environmental health. The journal encourages the open dissemination of innovative research and critical reviews that explore the mechanisms, effects, and management of toxic substances, thus ensuring that vital research outcomes reach a global audience. For those looking to keep abreast of cutting-edge developments in the field, Toxins is an indispensable platform for scientific exchange and collaboration.

Cutaneous and Ocular Toxicology, published by Taylor & Francis Ltd, is an essential resource in the fields of toxicology and pharmacology, focusing specifically on the effects of substances on the skin and eyes. With an ISSN of 1556-9527 and an E-ISSN of 1556-9535, this journal has been a vital platform for disseminating research since its inception in 1982, continuing its contributions to the scientific community through to 2024. Recognized for its academic rigor, it currently holds a Q3 ranking in the Medicine (miscellaneous) and Toxicology categories, reflecting its value among researchers and practitioners. The open access option enhances the journal's visibility and allows wider dissemination of knowledge, making it a key resource for professionals, students, and researchers dedicated to understanding and mitigating toxicological effects. Situated in the United Kingdom, Cutaneous and Ocular Toxicology strives to foster interdisciplinary collaboration and elevate the standards of toxicological research.

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.

Pesticide Biochemistry and Physiology, published by Academic Press Inc Elsevier Science, is a prominent peer-reviewed journal dedicated to advancing knowledge in the fields of agronomy, crop science, and the toxicological effects of pesticides. With an established history since 1971, this journal aims to provide a platform for researchers and professionals to share groundbreaking studies that bridge the gap between agricultural practices and environmental health. Holding a remarkable Q1 ranking in both Agronomy and Crop Science as well as Health, Toxicology, and Mutagenesis, it reflects the journal's commitment to high-quality research. The journal is essential reading for anyone involved in the sustainability of agricultural ecosystems, offering insights into the biochemical interactions of pesticides and their physiological impacts on various crops and non-target organisms. As the global demand for sustainable agricultural practices escalates, Pesticide Biochemistry and Physiology remains at the forefront, promoting innovative research to ensure both food security and environmental safety. Converged through an extensive range of studies, this journal is a valuable resource for researchers, professionals, and students aiming to make significant contributions to the evolving landscape of pesticide biochemistry.

Journal of Biochemical and Molecular Toxicology, published by Wiley, plays a pivotal role in the advancement of knowledge within the fields of biochemistry, toxicology, and molecular biology. Established in 1998, this esteemed journal has garnered a significant reputation, evidenced by its current placement in the Q2 quartile across several categories, including Biochemistry, Health, Toxicology and Mutagenesis, and Medicine. With an ISSN of 1095-6670 and an E-ISSN of 1099-0461, it serves an international audience, offering critical insights and innovative research that shape our understanding of biochemical interactions and toxicological assessments. While it does not operate on an open-access model, the journal ensures rigorous peer review and high-quality publication standards, making it a valuable resource for researchers, professionals, and students dedicated to the exploration of molecular toxicology. The journal's recognized impact within the scientific community is reflected in its competitive rankings among specialized journals, fostering significant contributions to both academic and applied contexts.

CELL BIOLOGY AND TOXICOLOGY, published by SPRINGER, stands as a vital journal within the realms of cell biology and toxicology, boasting an impressive 2023 Q1 ranking in its fields, alongside robust Scopus rankings placing it in the top 11th percentile for Toxicology and the 22nd for Health, Toxicology and Mutagenesis. With an ISSN of 0742-2091 and an E-ISSN of 1573-6822, the journal has been a cornerstone of scientific discourse since its inception in 1984, and will continue to converge innovative research until 2024. The journal focuses on the interplay between cellular mechanisms and toxicological implications, making it an essential resource for researchers, healthcare professionals, and students keen on advancing their understanding of these critical areas. Although it does not offer open access, its high impact and prestigious standing ensure that its publications reach a wide audience dedicated to significant advancements in the life sciences.

CRITICAL REVIEWS IN TOXICOLOGY, published by Taylor & Francis Ltd, stands as a preeminent journal within the field of toxicology, boasting an impressive Q1 ranking and holding the distinction of being ranked 12th out of 133 in the toxicology category according to Scopus, placing it in the top 91st percentile. With a continuous publication history since 1971 and a commitment to providing high-quality reviews, the journal offers critical insight into the latest research and advancements in toxicological sciences. While it is not an open-access journal, it provides numerous access options for both subscribers and institutions, ensuring that its extensive articles are widely available to the academic community. The journal's objectives are to disseminate comprehensive reviews that foster understanding and innovation in the assessment of chemical risks, environmental impacts, and the mechanisms of toxicity, making it an invaluable resource for researchers, professionals, and students dedicated to the science of toxicology.